SB747651A-PEG1-pomalidomide

Target: SB747651A-PEG1-pomalidomide is designed to target MSK1 kinase for CRBN recruitment.

Binding site: Its SB747651A moiety binds the ATP pocket of MSK1 kinase.

Mechanism of action: SB747651A-PEG1-pomalidomide is a putative CRBN-recruiting MSK1 degrader scaffold that combines the ATP-competitive MSK1 inhibitor SB-747651A with a pomalidomide-based cereblon ligand through a short PEG1 linker. The design is intended to recruit MSK1 or related SB-747651A-engaged kinases to CRL4CRBN ubiquitination machinery, converting kinase binding into potential proteasome-dependent degradation. This compound is most useful for exploratory PROTAC optimization, linker-length comparison, E3 recruitment studies, and evaluating whether MSK1 occupancy can support productive ternary-complex formation and kinase depletion.

• PROTAC-Mediated Oncoprotein Degradation: SB747651A-PEG1-pomalidomide is utilized in research to selectively degrade oncogenic proteins. By leveraging the ubiquitin-proteasome system, this PROTAC facilitates the targeted degradation of cancer-related proteins, offering a novel approach for studying oncogenesis and potential therapeutic interventions.

• Targeted Degradation of Kinases: This PROTAC compound is instrumental in the selective degradation of kinases, pivotal in signaling pathways. Researchers employ SB747651A-PEG1-pomalidomide to dissect kinase roles in cellular processes, providing insights into kinase-driven diseases and aiding in the development of kinase-targeted therapies.

• Protein Homeostasis Studies: SB747651A-PEG1-pomalidomide serves as a critical tool in exploring protein homeostasis mechanisms. By inducing the degradation of specific proteins, it allows scientists to investigate the dynamic balance of protein synthesis and degradation, enhancing understanding of proteostasis in various biological contexts.

• E3 Ligase Modulation Research: This PROTAC is used to study the modulation of E3 ligase activity, a key component of the ubiquitin-proteasome system. SB747651A-PEG1-pomalidomide aids in elucidating the roles of E3 ligases in protein degradation pathways, offering valuable insights into their regulatory functions and potential as therapeutic targets.